Highly accomplished physician-scientist and transformative industry executive with over two decades of leadership across academic, large pharma, and biotech sectors. Demonstrates a rare blend of clinical expertise in immuno-oncology, biologics, targeted therapies, and AI-driven drug discovery. Adept at bridging the gap between clinical oncology, translational research, and strategic business development, with a proven track record in pioneering healthcare solutions, driving innovation, and fostering entrepreneurship to address global medical challenges.Key expertise and achievements:Pioneered strategic initiatives in drug development, leading to significant advancements in cancer treatment and patient care.Spearheaded the development and commercialization of groundbreaking therapies, overseeing research, business development, and licensing with a keen eye for innovation and market needs.Expert in clinical trial design and execution, regulatory affairs, and engaging with investors, demonstrated through successful capital raises and IPO strategies.Established and led cross-functional teams, fostering an environment of collaboration and excellence in pursuit of therapeutic breakthroughs.Leveraged executive business training from Wharton School to enhance strategic planning, innovation, and entrepreneurship within the healthcare sector.Specialties and passions:Cancer drug development; company strategy from clinical and business perspective; immuno-oncology; cell and gene therapy; translational oncology; prophylactic vaccines and therapeutic cancer vaccines; investor meetings; healthcare conferences; analyst engagements; medical affairs and advisory boards; regulatory experience with FDA, EMA, PMDA; biomarker development; scientific expertise and strong KOL relationships in oncology; product development; team leadership and mentoring, development of team members; collaborations; business development; strategic innovation; competitive intelligence and due diligence; virtual health services connecting patients to care; digital marketing; R&D commercialization; cancer care access and equity; compassionate use and expanded access protocols for patients;Key Wharton Courses: Executive Leadership, Marketing, Negotiation, Strategic Innovation, Finance, Healthcare Strategy